Kairos Pharma (KAPA) Stock Chart & Stock Price History $0.93 0.00 (0.00%) As of 07/25/2025 04:10 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartHeadlinesOwnershipSEC FilingsBuy This Stock Kairos Pharma Stock Price Performance The Kairos Pharma (KAPA) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 38.82%. In the past month, the stock has increased 39.01%, reflecting recent market activity. As of the latest close, Kairos Pharma traded at $0.93 with a market cap of $15.67 million and volume of 491,773 shares. Receive KAPA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kairos Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-9.71%1 Month Performance+39.01%3 Month Performance+7.27%Year-To-Date Performance-38.82% KAPA Stock Chart for Sunday, July, 27, 2025 KAPA Chart by TradingView Kairos Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/25/2025$0.93$0.93$0.96$0.90491,773 shs$15.67 million07/24/2025$0.98$0.93-5.10%$1.01$0.93866,413 shs$15.67 million07/23/2025$1.03$0.98-4.85%$1.04$0.98565,137 shs$16.51 million07/22/2025$1.01$1.03+1.98%$1.04$0.96710,170 shs$17.36 million07/21/2025$1.08$1.01-6.48%$1.13$1.011.10 million shs$17.02 million07/18/2025$1.02$1.08+5.88%$1.23$0.913.97 million shs$18.20 million07/17/2025$1.09$1.02-6.42%$1.18$0.993.54 million shs$17.19 million07/16/2025$1.17$1.09-6.84%$1.15$0.998.69 million shs$18.37 million07/15/2025$0.69$1.17+70.78%$1.82$1.02241.73 million shs$19.71 million07/14/2025$0.71$0.69-3.51%$0.74$0.68366,289 shs$11.54 million Get the Latest News and Ratings for KAPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kairos Pharma and its competitors with MarketBeat's FREE daily newsletter. 07/11/2025$0.71$0.71-0.14%$0.71$0.68283,452 shs$11.96 million07/10/2025$0.74$0.71-3.27%$0.73$0.68332,033 shs$11.98 million07/09/2025$0.66$0.74+10.69%$0.74$0.65477,936 shs$12.39 million07/08/2025$0.66$0.66+0.15%$0.69$0.64401,265 shs$11.19 million07/07/2025$0.65$0.66+1.84%$0.68$0.64347,446 shs$11.17 million07/04/2025$0.65$0.65$0.69$0.65188,855 shs$10.97 million07/03/2025$0.70$0.65-6.33%$0.69$0.65188,855 shs$10.97 million07/02/2025$0.70$0.70-0.71%$0.70$0.65700,842 shs$11.71 million07/01/2025$0.71$0.70-1.27%$0.71$0.64666,159 shs$11.80 million06/30/2025$0.67$0.71+5.98%$0.74$0.641.51 million shs$11.95 million06/27/2025$0.69$0.67-3.04%$0.71$0.65470,149 shs$11.27 million06/26/2025$0.63$0.69+9.35%$0.70$0.60835,413 shs$11.63 million Related Companies Assertio Stock Chart Forte Biosciences Stock Chart Biomea Fusion Stock Chart Genenta Science Stock Chart Cue Biopharma Stock Chart Applied Therapeutics Stock Chart Verrica Pharmaceuticals Stock Chart Repare Therapeutics Stock Chart PMV Pharmaceuticals Stock Chart Quantum Biopharma Stock Chart Receive KAPA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kairos Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEAMERICAN:KAPA) was last updated on 7/27/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredThe big winner of Crypto week?It’s Crypto Week at the White House — and the sector is moving from fringe to full-scale adoption. With Bit...Weiss Ratings | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kairos Pharma, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kairos Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
